Modifying the Protease, Antiprotease Pattern by Elafin Overexpression Protects Mice From Colitis - Archive ouverte HAL Access content directly
Journal Articles Gastroenterology Year : 2010

Modifying the Protease, Antiprotease Pattern by Elafin Overexpression Protects Mice From Colitis

(1) , (2) , (2) , (1) , (1) , (1) , (2) , (3) , (4) , (5) , (5) , (1, 6) , (7) , (7) , (2) , (1) , (2)
1
2
3
4
5
6
7
Delphyne Descamps
Corinne Rolland
  • Function : Author
  • PersonId : 916000
Dieter Jenne

Abstract

BACKGROUND & AIMS:: Colon tissues of patients with inflammatory bowel disease (IBD) have been reported to have increased proteolytic activity, but no studies have clearly addressed the protease to anti-protease balance in the pathogenesis of colitis. We investigated the role of Elafin, a serine protease inhibitor expressed by skin and mucosal surfaces in human inflammatory conditions, and the proteases neutrophil elastase (NE) and proteinase-3 (PR-3), in mice with colitis. METHODS:: We studied mice with heterozygous disruptions in NE and PR-3and 2 strains of mice that express transgenic human elafin (an inhibitor of NE and PR-3). Trinitrobenzene sulfonic acid (TNBS) or dextran sodium sulphate (DSS) was used to induce colitis. Protease and cytokine levels were measured in colonic tissues collected from the mice. CaCO(2) and HT29 cells were studied in assays for cytokine expression and permeability. RESULTS:: Mice that expressed transgenic elafin developed less colitis and had reduced levels of proteases than wild-type mice following administration of TNBS or DSS. Expression of elafin did not modify activities of elastase or PR-3, but inhibited their increase upon the induction of colitis. Mice that expressed reduced levels of NE and PR-3 were protected against DSS-induced colitis. Elafin expression altered the patterns of inflammatory mediators and strengthened intestinal epithelial barrier functions in cells and colonic tissues from mice. CONCLUSIONS:: The protease inhibitor Elafin prevents intestinal inflammation in a mouse model of colitis and might be developed as a therapeutic agent for IBD.
Fichier principal
Vignette du fichier
Motta_et_al_Oct._2010_last_unmarked.pdf (323.69 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Loading...

Dates and versions

pasteur-00552947 , version 1 (06-01-2011)

Licence

Copyright

Identifiers

Cite

Jean-Paul Motta*, Laurent Magne*, Delphyne Descamps, Corinne Rolland, Camila Squarzoni-Dale, et al.. Modifying the Protease, Antiprotease Pattern by Elafin Overexpression Protects Mice From Colitis. Gastroenterology, 2010, 140 (4), pp.1272-82. ⟨10.1053/j.gastro.2010.12.050⟩. ⟨pasteur-00552947⟩
678 View
680 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More